Market Overview

ASX 200 Index

No movers to display
Immutep TACTI-004 NSCLC Trial At 50% Enrolment, Paving Way for Futility Analysis
Biotechnology

Immutep TACTI-004 NSCLC Trial At 50% Enrolment, Paving Way for Futility Analysis

Immutep (ASX: IMM) has achieved a significant milestone, announcing 50% patient enrolment in its global Phase III TACTI-004 trial for first-line non-small ce

1 min read
Isla Campbell
Isla Campbell
Island Pharmaceuticals Raises $9m to Fund Clinical Development as FDA Approves Galidesivir Pathway
Biotechnology

Island Pharmaceuticals Raises $9m to Fund Clinical Development as FDA Approves Galidesivir Pathway

Island Pharmaceuticals (ASX: ILA) secures FDA Animal Rule path for galidesivir and $9m funding to fast-track two-stage trials and US govt procurement potential.

1 min read
Imelda Cotton
Imelda Cotton
Rhythm Biosciences Secures Key Manufacturing Deal for ColoSTAT
Biotechnology

Rhythm Biosciences Secures Key Manufacturing Deal for ColoSTAT

Rhythm Biosciences (ASX:RHY) has secured a multi-year manufacturing agreement with Quansys Biosciences for its ColoSTAT reagent kits, ensuring scalab

1 min read
Isla Campbell
Isla Campbell
Neurotech International Secures HREC Approval for Pivotal Phase 3 ASD Study of NTI164
Biotechnology

Neurotech International Secures HREC Approval for Pivotal Phase 3 ASD Study of NTI164

Neurotech International (ASX: NTI) has secured Human Research Ethics Committee (HREC) approval to commence its pivotal Phase 3 clinical study for **NTI16

2 min read
Isla Campbell
Isla Campbell
Join 100,000+ Investors

Never Miss a Market Move

Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.

Free weekly newsletter. Unsubscribe anytime.

Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
TechnologyUpcoming IPOs

Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO

Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]

3 min read
Filip Karinja
Filip Karinja
Stormeur IPO to expand non-surgical cosmetics empire
Industrials & JuniorsUpcoming IPOs

Stormeur IPO to expand non-surgical cosmetics empire

Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]

2 min read
Imelda Cotton
Imelda Cotton
ASX anticipates surge of IPOs later in 2024
Hot TopicsUpcoming IPOs

ASX anticipates surge of IPOs later in 2024

Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]

2 min read
Imelda Cotton
Imelda Cotton
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
Industrials & JuniorsUpcoming IPOs

Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion

In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]

1 min read
Filip Karinja
Filip Karinja